Time to commencement of effective treatment in patients with drug-resistant tuberculosis diagnosed in the Torres Strait / Papua New Guinea cross-border region

Author:

Foster J’Belle,Mendez Diana,Marais Ben J.,Peniyamina Dunstan,McBryde Emma S.

Abstract

ABSTRACTIntroductionDelays between self-reported symptom onset and commencement of effective treatment contribute to ongoing tuberculosis (TB) transmission, which is a particular concern in patients with drug-resistant (DR)-TB. We assessed improvements in time to commencement of effective treatment in patients diagnosed with DR-TB in the Torres Strait / Papua New Guinea cross-border region.MethodsAll laboratory-confirmed DR-TB cases diagnosed in the Torres Strait between 1 March 2000 and 31 March 2020 were reviewed. We assessed the total time from self-reported onset of symptoms to effective treatment commencement in different programmatic time periods. Pairwise analyses and time to event proportional hazard calculations were used to explore the association between delays in median time to effective treatment, and selected variables. Data were further analysed to examine predictors of excessive treatment delay.ResultsThe median number of days from self-reported onset of symptoms to effective treatment commencement was 124 days (interquartile range 51-214) over two decades. Between 2006 and 2012, most (57%) cases exceeded this ‘grand median’ while the median ‘time to treat’ in the most recent time period (2016-2020) was significantly reduced to 29 days (p<0.001). Although there was a reduction in the median ‘time to treat’ with the introduction of Xpert MTB/RIF (135 days pre-Xpert vs 67 days post-Xpert) this was not statistically significant (p0.07). Establishment of the Torres and Cape TB Control Unit on Thursday Island (2016-2020) was significantly associated with reduced treatment delay, compared to previous TB program period (2000-2005p<0.04; 2006-2012p<0.001).ConclusionMinimising TB treatment delay in remote settings like the Torres Strait / Papua New Guinea cross-border region requires effective decentralised diagnosis and management structures. The results of this study suggest that the establishment of the Torres and Cape TB Control Unit on Thursday Island significantly improved time to commencement of effective TB treatment. Possible contributing factors include better TB education, cross-border communication and patient-centred care.

Publisher

Cold Spring Harbor Laboratory

Reference44 articles.

1. World Health Organization. Global tuberculosis report. Geneva, Switzerland: World Health Organization, 2020. Available: https://www.who.int/publications/i/item/9789240013131 (Accessed 24 March 2021).

2. Viney K. The Australian tuberculosis risk factor survey. Canberra, ACT: Australian National University, 2021. Available: https://nceph.anu.edu.au/research/projects/australian-tuberculosis-risk-factor-survey (Accessed 5 May, 2021).

3. Epidemiology of tuberculosis in Papua New Guinea: analysis of case notification and treatment-outcome data, 2008-2016;Western Pacific Surveillance and Response Journal,2018

4. Taukarai R. Systematic screening for tuberculosis launches in Papua New Guinea. Port Moresby, PNG: World Health Organization Western Pacific, 2018. Available: https://www.who.int/papuanewguinea/news/detail/13-02-2018-let-s-kick-tb-out-of-png (Accessed 15 December 2020).

5. Bento J , Duarte R , Brito MC , Leite SMRL , Caldeira MdC , Carvalho A. Malabsorption of antimycobacterial drugs as a cause of treatment failure in tuberculosis. BMJ case reports 2010.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3